Correlation Between Virpax Pharmaceuticals and Zevra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Zevra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Zevra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Zevra Therapeutics, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Zevra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Zevra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Zevra Therapeutics.
Diversification Opportunities for Virpax Pharmaceuticals and Zevra Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Virpax and Zevra is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Zevra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zevra Therapeutics and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Zevra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zevra Therapeutics has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Zevra Therapeutics go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Zevra Therapeutics
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Zevra Therapeutics. In addition to that, Virpax Pharmaceuticals is 2.34 times more volatile than Zevra Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. Zevra Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 786.00 in Zevra Therapeutics on November 29, 2024 and sell it today you would lose (47.00) from holding Zevra Therapeutics or give up 5.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Zevra Therapeutics
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Zevra Therapeutics |
Virpax Pharmaceuticals and Zevra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Zevra Therapeutics
The main advantage of trading using opposite Virpax Pharmaceuticals and Zevra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Zevra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zevra Therapeutics will offset losses from the drop in Zevra Therapeutics' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Zevra Therapeutics vs. Transcode Therapeutics | Zevra Therapeutics vs. Fortress Biotech | Zevra Therapeutics vs. Akebia Ther | Zevra Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |